Skip to main content

Table 1 Clinical Characteristics of Group A (no intervention) and Group B (intervention)

From: A psychoeducational intervention reduces the need for anesthesia during radiotherapy for young childhood cancer patients

 

Group A

No Intervention

Group B

Intervention

P

 

N

(%)

N

(%)

 

Number of RT courses

154

63.1%

90

36.9%

 

Number of RT fractions

2580

62.3%

1561

37.7%

 

   Sex

     

Male

103

66.9%

61

67.8%

 

Female

51

33.1%

29

32.2%

 

   Age

     

Median

7.9

 

8.1

  

Mean

9

 

8.9

  

Range

0.0 – 19.0

 

1.6 – 19.1

  

   Anesthesia

     

Yes

33

21.4%

8

8.9%

p = 0.015

No

121

78.6%

82

91.1%

 

   Age of those with anesthesia (Years)

     

Median

3.2

 

2.7

 

p < 0.001

Mean

3.2

 

2.7

  

Range

0.0 – 12.0

 

1.6 – 4.3

  

Standard Deviation

2.1

 

0.9

  

   Total dose of irradiation (Gray)

     

Median

24.0

 

20.0

  

Mean

28.9

 

31.2

  

Range *

4.0 – 59.4

 

6.0 – 68.0

  

Standard Deviation

16.8

 

19.0

  

   Total times of irradiation

     

Median

12.5

 

12.0

  

Mean

16.8

 

17.3

  

Range

1.0 – 54.0

 

3.0 – 36.0

  

Standard Deviation

10.3

 

10.6

  

   Diagnostic group

     

CNS tumor

31

20.1%

25

27.8%

 

Leukemia/Lymphoma

67

43.5%

43

47.8%

 

Solid tumor

56

36.4%

22

24.4%

 

   Site of irradiation

     

Cranial irradiation

98

63.6%

56

62.2%

 

Extracranial irradiation

56

36.4%

34

37.8%

 

   Positioning

     

Prone position

19

12.3%

19

21.1%

 

Supine position

129

83.8%

64

71.1%

 

Other position

6

3.9%

7

7.8%

 

   Intent of Radiotherapy

     

Curative

132

85.7%

83

92.2%

 

Palliative

22

14.3%

7

7.8%

 
  1. Calculation of clinical characteristics is based on number of RT courses and not RT fractions.
  2. In 6 patients in group A and 4 patients in group B low total irradiation dosages of 4 to 6 Gray were applied for pain reduction for palliative treatment, and 4.5 and 6 Gray in a curative setting in two infants with neuroblastoma in Group B.